Trial Outcomes & Findings for Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds (NCT NCT02803164)

NCT ID: NCT02803164

Last Updated: 2021-09-29

Results Overview

The total number of days of receiving NWPT

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

21 participants

Primary outcome timeframe

12 month follow up

Results posted on

2021-09-29

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
Overall Study
STARTED
10
11
Overall Study
COMPLETED
10
11
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Control Group
n=11 Participants
Historical chest wound treatment.
Total
n=21 Participants
Total of all reporting groups
Age, Continuous
61 years
n=10 Participants
62 years
n=11 Participants
62 years
n=21 Participants
Sex: Female, Male
Female
7 Participants
n=10 Participants
1 Participants
n=11 Participants
8 Participants
n=21 Participants
Sex: Female, Male
Male
3 Participants
n=10 Participants
10 Participants
n=11 Participants
13 Participants
n=21 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
10 participants
n=10 Participants
11 participants
n=11 Participants
21 participants
n=21 Participants

PRIMARY outcome

Timeframe: 12 month follow up

Population: Data not collected or analyzed for the Historical Control arm. This arm did not receive the NWPT.

The total number of days of receiving NWPT

Outcome measures

Outcome measures
Measure
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
Duration of Negative Pressure Wound Therapy (NWPT)
8 Days
Interval 2.0 to 29.0

SECONDARY outcome

Timeframe: 12 months

The total number of days to wound closure

Outcome measures

Outcome measures
Measure
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
n=11 Participants
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
Wound Closure
7 Days
Interval 4.0 to 49.0
18 Days
Interval 4.0 to 179.0

SECONDARY outcome

Timeframe: 12 months

The total number of days in hospital

Outcome measures

Outcome measures
Measure
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
n=11 Participants
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
Length of Hospital Stay
6 Days
Interval 1.0 to 43.0
25 Days
Interval 3.0 to 152.0

Adverse Events

Intervention

Serious events: 2 serious events
Other events: 2 other events
Deaths: 2 deaths

Historical Control

Serious events: 11 serious events
Other events: 8 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Intervention
n=10 participants at risk
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
n=11 participants at risk
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
Infections and infestations
Sepsis
10.0%
1/10 • Number of events 1 • 1 year
63.6%
7/11 • Number of events 7 • 1 year
Cardiac disorders
Major cardiac event
0.00%
0/10 • 1 year
9.1%
1/11 • Number of events 1 • 1 year
Respiratory, thoracic and mediastinal disorders
Air Embolism
0.00%
0/10 • 1 year
9.1%
1/11 • Number of events 1 • 1 year
Respiratory, thoracic and mediastinal disorders
Reintubation
0.00%
0/10 • 1 year
18.2%
2/11 • Number of events 2 • 1 year
Respiratory, thoracic and mediastinal disorders
Acute Respiratory Distress Syndrome
0.00%
0/10 • 1 year
9.1%
1/11 • Number of events 1 • 1 year
Renal and urinary disorders
Acute kidney failure
0.00%
0/10 • 1 year
9.1%
1/11 • Number of events 1 • 1 year
Respiratory, thoracic and mediastinal disorders
Hemothorax
10.0%
1/10 • Number of events 1 • 1 year
9.1%
1/11 • Number of events 1 • 1 year

Other adverse events

Other adverse events
Measure
Intervention
n=10 participants at risk
Treatment of wound with Vacuum-assisted dressing. Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
Historical Control
n=11 participants at risk
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
Cardiac disorders
Atrial fibrillation
0.00%
0/10 • 1 year
45.5%
5/11 • Number of events 5 • 1 year
Respiratory, thoracic and mediastinal disorders
pneumonia
10.0%
1/10 • Number of events 1 • 1 year
27.3%
3/11 • Number of events 3 • 1 year
General disorders
Wound dehiscence
10.0%
1/10 • Number of events 1 • 1 year
0.00%
0/11 • 1 year

Additional Information

Dr. Mathew Thomas

Mayo Clinic

Phone: 904-953-2000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place